NYSE:MCK - McKesson Stock Price, Price Target & More

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

McKesson declared a quarterly dividend on Thursday, April 26th. Shareholders of record on Friday, June 1st will be given a dividend of $0.34 per share on Monday, July 2nd. This represents a $1.36 annualized dividend and a dividend yield of 1.00%. The ex-dividend date is Thursday, May 31st. View McKesson's Dividend History.

McKesson announced that its Board of Directors has initiated a stock repurchase plan on Thursday, October 27th 2016, which allows the company to repurchase $4,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 114% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board believes its shares are undervalued.

McKesson Co. (NYSE:MCK) released its earnings results on Thursday, May, 24th. The company reported $3.49 EPS for the quarter, missing analysts' consensus estimates of $3.56 by $0.07. The firm earned $51.63 billion during the quarter, compared to analysts' expectations of $51.36 billion. McKesson had a return on equity of 23.55% and a net margin of 0.03%. McKesson's revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.41 earnings per share. View McKesson's Earnings History.

McKesson is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for McKesson.

McKesson updated its FY19 earnings guidance on Thursday, June, 28th. The company provided EPS guidance of $13.00-13.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.34. McKesson also updated its Q1 guidance to $2.85-2.95 EPS.

14 brokerages have issued 1 year price targets for McKesson's stock. Their forecasts range from $130.00 to $205.00. On average, they expect McKesson's share price to reach $171.8462 in the next twelve months. This suggests a possible upside of 25.8% from the stock's current price. View Analyst Ratings for McKesson.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 1 sell rating, 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to McKesson include AmerisourceBergen (ABC), Cardinal Health (CAH), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), biOasis Technologies (BIOAF), Trxade Group (TRXD) and Medizone International (MZEI).

Media stories about MCK stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. McKesson earned a coverage optimism score of 0.07 on Accern's scale. They also assigned news headlines about the company an impact score of 47.53 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

McKesson's stock is owned by many different of institutional and retail investors. Top institutional investors include Swedbank (0.31%), Hexavest Inc. (0.20%), Rockland Trust Co. (0.03%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%), Founders Capital Management LLC (0.03%) and Clinton Group Inc. (0.02%). Company insiders that own McKesson stock include Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Susan R Salka and Wayne A Budd. View Institutional Ownership Trends for McKesson.

MCK stock was sold by a variety of institutional investors in the last quarter, including Investment House LLC, Acropolis Investment Management LLC, NN Investment Partners Holdings N.V., Atria Investments LLC, American National Bank, Trust Department MB Financial Bank N A, Gateway Investment Advisers LLC and Park National Corp OH. Company insiders that have sold McKesson company stock in the last year include Erin M Lampert, John H Hammergren, M Christine Jacobs and Marie L/Ca Knowles. View Insider Buying and Selling for McKesson.

MCK stock was bought by a variety of institutional investors in the last quarter, including Clinton Group Inc., Founders Capital Management LLC, Swedbank, State of Alaska Department of Revenue, DnB Asset Management AS, IFM Investors Pty Ltd, Campbell & CO Investment Adviser LLC and Rockland Trust Co.. Company insiders that have bought McKesson stock in the last two years include Lori A Schechter and Susan R Salka. View Insider Buying and Selling for McKesson.

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MCK stock can currently be purchased for approximately $136.59.

McKesson has a market capitalization of $27.56 billion and generates $208.36 billion in revenue each year. The company earns $67 million in net income (profit) each year or $12.62 on an earnings per share basis. McKesson employs 78,000 workers across the globe.

McKesson's mailing address is ONE POST ST, SAN FRANCISCO CA, 94104. The company can be reached via phone at 415-983-8300 or via email at [email protected]